Results 141 to 150 of about 52,591 (172)

An amino acid insertion in the PHI loop of the VP2 capsid protein of serotype 1 infectious bursal disease virus deeply modifies its antigenicity and abrogates its propagation into B cells. [PDF]

Vet Res
Le Nouën C, Courtillon C, Soubies SM, Cruz P, Dolan MA, Toquin D, Macaigne M, Amelot M, Keita A, Müller H, Härtle S, Eterradossi N.   +11 more
europepmc   +1 more source

Engineered VP2-NC antigen expressed in an NDV vector elicits enhanced protection against the challenge of the novel variant infectious bursal disease virus. [PDF]

Poult Sci
Zhang Z, Liu C, Zhang Y, Dai J, Tan L, Sun Y, Song C, Qu Y, Tang N, Liao Y, Ding C, Qiu X.   +11 more
europepmc   +1 more source

Molecular Characterization of Representative CPV-2c Isolates and Establishment of VP2-Targeted Nanobody-Based Immunodetection Tools. [PDF]

Animals (Basel)
Liu L, Xia M, Hou C, Chen D, Li C, Chen X, Chu Q, Sun Y, Liu S, Li Y, Wang H, Zhu Y, Yang M, Wang H, Li C, Yang X.   +15 more
europepmc   +1 more source

Genetic Diversity and Evolutionary Dynamics of Feline Panleukopenia Virus in China: Phylogenetic Analysis and Substitution Patterns in NS1 and VP2 Proteins. [PDF]

Viruses
Ye Z, Wu D, Jiang X, Liu L, Luo G, Wang Z, Cheng Y, Feng E.   +7 more
europepmc   +1 more source

A novel replication-deficient feline herpesvirus type 1 vector-based vaccine provides strong immune protection in cats. [PDF]

J Virol
Heng W, Zhou Z, Lin W, Zhang X, Qi R, Wei C, Jiang Q, Kang H, Jia H, Liu J.   +9 more
europepmc   +1 more source

In Silico Saturation-Mutagenesis-Based Genomic Mutation Risk Assessment for Enterovirus B. [PDF]

Viruses
Wang L, Tang J, Jia Y, Tong X, Ying X, Chen Q, Dong C.   +6 more
europepmc   +1 more source

Expression of bluetongue virus core proteins VP2 and VP7 by bovine herpesvirus-4 confers protection against virulent challenge in a mouse model. [PDF]

Vet Res
Franceschi V, Nogales-Altozano P, Rojas JM, Minesso S, Sevilla N, Donofrio G, Martín V.   +6 more
europepmc   +1 more source

HSPA5 induces autophagy targeting VP2 through the PERK-eIF2α signaling pathway to inhibit SVA replication. [PDF]

J Virol
Li L, Bi R, Li J, Chang M, Zhao J, Wang X, Wei L, Chang X, Cheng Y, Yin Z, Wang J, Zhou Y, Bo Z, Shen H, Yan J, Liu X, Sun P.   +16 more
europepmc   +1 more source

Development of a recombinant chimeric Newcastle disease virus-vectored vaccine conferring single-dose, triple protection against genotype VII NDV, IBDV, and H9N2 AIV. [PDF]

Poult Sci
Yang P, Xiang M, Tian K, Xu M, Zhu Y, Qiu L, Xu M, Zhang B, Zhang Y, Qiu J, Yang D, Qiao Q, Cong Y, Wang B, Li J, Zhao J.   +15 more
europepmc   +1 more source

Enterovirus Testing in Hand, Foot, and Mouth Disease and Herpangina: A Highly Sensitive Single-Round VP4-VP2 Reverse-Transcription Polymerase Chain Reaction Assay with a Redesigned Reverse Primer. [PDF]

Viruses
Fujimoto T, Ogi M, Kitakawa K, Sano T, Nishimura Y, Kitamura K, Ueno MK, Arita M.   +7 more
europepmc   +1 more source